Publications
577 results found
Blamire AM, Cader S, Lee M, et al., 2007, Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy, MAGNETIC RESONANCE IN MEDICINE, Vol: 58, Pages: 880-885, ISSN: 0740-3194
- Author Web Link
- Cite
- Citations: 36
Tomassini V, Jbabdi S, Klein JC, et al., 2007, Diffusion-weighted Imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations, JOURNAL OF NEUROSCIENCE, Vol: 27, Pages: 10259-10269, ISSN: 0270-6474
- Author Web Link
- Cite
- Citations: 197
Giorgio A, Watkins KE, Douaud G, et al., 2007, Developmental changes in white matter microstructure in adolescence, ABN Spring Scientific Meeting 2007, Publisher: B M J PUBLISHING GROUP, Pages: 1019-1020, ISSN: 0022-3050
- Author Web Link
- Cite
- Citations: 1
Stagg CJ, Kincses ZT, Palace J, et al., 2007, Transcranial direct current stimulation: A potential tool for rehabilitation?, ABN Spring Scientific Meeting 2007, Publisher: B M J PUBLISHING GROUP, Pages: 1036-1036, ISSN: 0022-3050
Douaud G, Smith S, Jenkinson M, et al., 2007, Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia, BRAIN, Vol: 130, Pages: 2375-2386, ISSN: 0006-8950
- Author Web Link
- Cite
- Citations: 390
Tomassini V, Jbabdi S, Klein JC, et al., 2007, Diffusion tensor imaging defines subregions of human lateral premotor cortex with distinct frontoparietal connections, ABN Spring Scientific Meeting 2007, Publisher: B M J PUBLISHING GROUP, Pages: 1028-1028, ISSN: 0022-3050
Smith SM, Rao A, De Stefano N, et al., 2007, Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX, NEUROIMAGE, Vol: 36, Pages: 1200-1206, ISSN: 1053-8119
- Author Web Link
- Cite
- Citations: 83
Matthews PM, 2007, Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease, NATURE CLINICAL PRACTICE NEUROLOGY, Vol: 3, Pages: 366-367, ISSN: 1745-834X
- Author Web Link
- Cite
- Citations: 1
Bhagwagar Z, Wylezinska M, Jezzard P, et al., 2007, Reduction in occipital cortex GABA concentrations in medication free recovered bipolar subjects, International Conference on Bipolar Disorder, Publisher: BLACKWELL PUBLISHING, Pages: 21-21, ISSN: 1398-5647
Cader S, Johansen-Berg H, Wylezinska M, et al., 2007, Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis, NEUROIMAGE, Vol: 36, Pages: 19-27, ISSN: 1053-8119
- Author Web Link
- Cite
- Citations: 74
Bhagwagar Z, Wylezinska M, Jezzard P, et al., 2007, Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects, BIOLOGICAL PSYCHIATRY, Vol: 61, Pages: 806-812, ISSN: 0006-3223
- Author Web Link
- Cite
- Citations: 166
Peineau S, Taghibiglou C, Bradley C, et al., 2007, UP inhibits LTD in the hippocampus via regulation of GSK3 beta, NEURON, Vol: 53, Pages: 703-717, ISSN: 0896-6273
- Author Web Link
- Cite
- Citations: 406
Matthews PM, Talbot K, 2007, Magnetic resonance spectroscopic imaging - of prognostic value in amyotrophic lateral sclerosis?, NATURE CLINICAL PRACTICE NEUROLOGY, Vol: 3, Pages: 76-77, ISSN: 1745-834X
- Author Web Link
- Cite
- Citations: 1
Morgan RM, Parry AMM, Arida RM, et al., 2007, Effects of elevated plasma tryptophan on brain activation associated with the Stroop task, PSYCHOPHARMACOLOGY, Vol: 190, Pages: 383-389, ISSN: 0033-3158
- Author Web Link
- Cite
- Citations: 11
Zarei M, Johansen-Berg H, Jenkinson M, et al., 2007, Two-dimensional population map of cortical connections in the human internal capsule, JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol: 25, Pages: 48-54, ISSN: 1053-1807
- Author Web Link
- Cite
- Citations: 43
Schloesser RGM, Nenadic I, Wagner G, et al., 2007, White matter abnormalities and brain activation in schizophrenia: A combined DTI and fMRI study, SCHIZOPHRENIA RESEARCH, Vol: 89, Pages: 1-11, ISSN: 0920-9964
- Author Web Link
- Cite
- Citations: 114
Pomeroy IM, Jordan EK, Frank J, et al., 2006, Neurodegeneration in a marmoset model of multiple sclerosis, Spring Meeting of the Association-of-British-Neurologists, Publisher: B M J PUBLISHING GROUP, Pages: 1399-1399, ISSN: 0022-3050
Ropele S, Schmidt H, Smith S, et al., 2006, Factors associated with progression of brain atrophy during ageing: 6 year follow-up from the Austrian stroke prevention study, Research and Practice in Alzheimer's Disease, Vol: 11, Pages: 227-233, ISSN: 1284-8360
Neuroimaging techniques are increasingly used to study mechanisms leading to cognitive impairment. In particular, brain atrophy has been proposed as a surrogate marker of dementia. However, little is known regarding confounding factors which might modulate the evolution of brain atrophy during ageing. We therefore determined the rate of atrophy over 6 years for 201 participants (F/M=96/105; 59.8±5.9 yrs) in the Austrian Stroke Prevention Study and probed the impact of baseline variables on its progression. The mean annual brain volume change was -0.40±0.29%. The rate of brain atrophy was significantly higher in subjects of greater age and those with higher HbA1c, higher body-mass-index, high alcohol intake, severe white matter hyperintensities, and in APOEε4-carriers. Multivariate analysis suggested that baseline brain volume, HbA1cand the extent of white matter hyperintensities explain a major proportion of variance in the rates of brain atrophy. These results indicate that neurologically asymptomatic elderly experience continuing brain volume loss, which appears to accelerate with age. HbA1cwas identified as a risk factor for a greater rate of brain atrophy. Clustering of factors associated with the so-called "metabolic syndrome" in subjects with high HbA1csuggests a link between this syndrome and late-life brain tissue loss. Together, this underscores the need to control for confounding factors in future Clinical trials and indicates possible new directions for intervention.
Abu-Omar Y, Cader S, Wolf LG, et al., 2006, Short-term changes in cerebral activity in on-pump and off-pump cardiac surgery defined by functional magnetic resonance imaging and their relationship to microembolization, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, Vol: 132, Pages: 1119-1125, ISSN: 0022-5223
- Author Web Link
- Cite
- Citations: 39
Manson SC, Palace J, Frank JA, et al., 2006, Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy, EXPERIMENTAL BRAIN RESEARCH, Vol: 174, Pages: 728-733, ISSN: 0014-4819
- Author Web Link
- Cite
- Citations: 46
Wegner C, Esiri MM, Chance SA, et al., 2006, Neocortical neuronal, synaptic, and glial loss in multiple sclerosis, NEUROLOGY, Vol: 67, Pages: 960-967, ISSN: 0028-3878
- Author Web Link
- Cite
- Citations: 243
Matthews PM, Honey GD, Bullmore ET, 2006, Applications of fMRI in translational medicine and clinical practice, NATURE REVIEWS NEUROSCIENCE, Vol: 7, Pages: 732-744, ISSN: 1471-0048
- Author Web Link
- Cite
- Citations: 163
Jamison HL, Watkins KE, Bishop DVM, et al., 2006, Hemispheric specialization for processing auditory nonspeech stimuli, CEREBRAL CORTEX, Vol: 16, Pages: 1266-1275, ISSN: 1047-3211
- Author Web Link
- Cite
- Citations: 107
Zarei M, Johansen-Berg H, Smith S, et al., 2006, Functional anatomy of interhemispheric cortical connections in the human brain, JOURNAL OF ANATOMY, Vol: 209, Pages: 311-320, ISSN: 0021-8782
- Author Web Link
- Cite
- Citations: 137
Farrugia ME, Robson MD, Kennett RP, et al., 2006, Facial muscle atrophy in musk antibody positive myasthenia gravis, EUROPEAN JOURNAL OF NEUROLOGY, Vol: 13, Pages: 23-23, ISSN: 1351-5101
, 2006, Noninvasive brain imaging for experimental medicine in drug discovery and development: Promise and pitfalls, International Journal of Pharmaceutical Medicine, Vol: 20, Pages: 167-175, ISSN: 1364-9027
There is currently increased focus on experimental medicine in drug development. Imaging methods potentially provide highly cost-effective, general approaches for the noninvasive characterisation of disease and pharmacokinetics, pharmacodynamics and drug effects directly in humans in ways that can enable this. The two methods most widely employed now are positron emission tomography (PET) and magnetic resonance imaging (MRI). PET allows the distribution of radiolabelled molecules to be mapped, enabling studies of molecule distribution and tissue metabolism. MRI was initially used primarily to define tissue structure, but a more recent range of functional MRI techniques promise the potential to define pharmacokinetic data over biologically meaningful timescales. With an understanding of the relationship between imaging biomarker changes and clinical outcomes, imaging can be used as a surrogate marker of response even for the later stages of drug development. There are pitfalls in the application of these methods, which need to be avoided. The two most common are: (i) getting distracted by the technology rather than focusing on the questions that need to be asked; and (ii) the failure to interpret the imaging data in an appropriate disease- and drug-specific fashion. However, with attention to such issues, imaging should prove a powerful facilitating platform for experimental medicine in the future. © 2006 Adis Data Information BV. All rights reserved.
Enzinger C, Smith S, Fazekas F, et al., 2006, Lesion probability maps of white matter hyperintensities in elderly individuals - Results of the Austrian stroke prevention study, JOURNAL OF NEUROLOGY, Vol: 253, Pages: 1064-1070, ISSN: 0340-5354
- Author Web Link
- Cite
- Citations: 47
Smith SM, Jenkinson M, Johansen-Berg H, et al., 2006, Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data, NEUROIMAGE, Vol: 31, Pages: 1487-1505, ISSN: 1053-8119
- Author Web Link
- Cite
- Citations: 3224
Ciccarelli O, Behrens TE, Altmann DR, et al., 2006, Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis, BRAIN, Vol: 129, Pages: 1859-1871, ISSN: 0006-8950
- Author Web Link
- Cite
- Citations: 136
Selvaraj S, Wylezinska M, Evans J, et al., 2006, Tryptophan depletion does not lower brain GABA levels in healthy volunteers, PSYCHOPHARMACOLOGY, Vol: 187, Pages: 131-132, ISSN: 0033-3158
- Author Web Link
- Cite
- Citations: 3
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.